Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: A nationwide population-based study
Research output: Contribution to journal › Article › peer-review
18Scopus
citations
Fingerprint
Dive into the research topics of 'Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: A nationwide population-based study'. Together they form a unique fingerprint.